Nektar Therapeutics (NKTR) Shares Plummet Below 1-Year High
The stock price of Nektar Therapeutics (NASDAQ: NKTR) has dropped by -3.71 compared to previous close of 0.90. Despite this, the company has seen a
The stock price of Nektar Therapeutics (NASDAQ: NKTR) has dropped by -3.71 compared to previous close of 0.90. Despite this, the company has seen a
Additionally, the 36-month beta value for NKTR is 0.89. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 5
The stock has a 36-month beta value of 0.86. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 5 as
In the past week, NKTR stock has gone up by 40.13%, with a monthly gain of 61.87% and a quarterly surge of 91.60%. The volatility
Nektar Therapeutics (NASDAQ: NKTR)’s stock price has soared by 11.94 in relation to previous closing price of 0.67. Nevertheless, the company has seen a gain
, and the 36-month beta value for NKTR is at 0.80. The public float for NKTR is 188.05M, and currently, shorts hold a 3.09% of
In the past week, NKTR stock has gone up by 9.34%, with a monthly gain of 14.38% and a quarterly surge of 11.33%. The volatility
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.